• Re-Evaluating ACE Inhibitor Specificity: Insights into Pepti

  2026-04-22

  This article examines the pivotal study by Tieku and Hooper (1992), which redefined our understanding of ACE inhibitors and their selectivity against key zinc-dependent aminopeptidases on mammalian cell surfaces. By systematically comparing major peptidase inhibitors, the research clarifies enzyme-inhibitor interactions relevant for cardiovascular and renal disease models.

• AMPK’s Dual Role in Autophagy: Insights from Energy Stress S

  2026-04-22

  This study overturns the prevailing model of AMPK as a universal activator of autophagy, revealing instead its inhibitory role on ULK1-mediated autophagy under glucose starvation. The findings clarify AMPK's nuanced regulatory functions and highlight implications for researchers targeting autophagy pathways in cancer and metabolic disease.

• Reliable Innate Immunity Assays with 2'3'-cGAMP (sodium salt

  2026-04-21

  This article addresses common laboratory challenges in cell-based assays involving the cGAS-STING pathway, highlighting how 2'3'-cGAMP (sodium salt) (SKU B8362) delivers data-backed solutions for reproducibility, sensitivity, and workflow compatibility. Drawing on recent literature and best-practice scenarios, it provides scientists with actionable insights for selecting and optimizing this reagent in innate immune and interferon induction studies.

• Strategic BACE1 Inhibition: LY2886721 and the Future of Alzh

  2026-04-21

  Explore how LY2886721, a nanomolar oral BACE1 inhibitor from APExBIO, is reshaping Alzheimer’s disease research by enabling precise amyloid beta reduction without compromising synaptic function. This thought-leadership article bridges mechanistic insight with practical strategy, integrating new evidence and expert workflow guidance for translational researchers.

• Gamithromycin: Mechanistic Insight and Translational Leverag

  2026-04-20

  This article offers an advanced, evidence-backed guide for translational researchers leveraging Gamithromycin (ML-1709460) in veterinary infectious disease models. By dissecting its mechanistic action, experimental variables, and recent susceptibility data, we provide actionable strategy for optimizing respiratory and mastitis protocols, emphasizing APExBIO’s leadership in compound quality and reproducibility.

• Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301): T

  2026-04-20

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide an efficient solution for purifying and isolating biotinylated molecules—including proteins, peptides, antibodies, and nucleic acids—where high specificity and low background are critical. The beads are best suited for workflows demanding rapid and reliable magnetic separation, such as immunoprecipitation, protein interaction studies, and nucleic acid purification. Use in applications beyond biotin–streptavidin capture, or where non-biotinylated targets are required, is not supported by current product specifications.

• Tirbanibulin Suppresses HPV Oncogenic Pathways in HeLa Cells

  2026-04-19

  This study demonstrates that tirbanibulin profoundly inhibits cell proliferation and downregulates key oncogenic and HPV-related proteins in HPV-18+ HeLa cells. The findings elucidate the drug’s impact on Src-MEK-ERK signaling and HPV oncoprotein expression, providing mechanistic insights relevant for cancer and virology research.

• Dihydroartemisinin: Mechanistic Leverage in Translational Re

  2026-04-18

  This article explores Dihydroartemisinin's mechanistic roles and translational potential, examining its mTOR pathway modulation, antimalarial action, and strategic positioning for next-generation cell-based research. Drawing from recent antiplasmodial insights and scenario-driven protocols, we guide researchers in deploying Dihydroartemisinin for robust, reproducible results across disease models.

• FGFR and TGFβ/PI3K/AKT Pathway Crosstalk Regulates Periostin

  2026-04-17

  Labrèche et al. uncover a novel mechanism regulating periostin expression in HER2-positive breast cancer cells, revealing how FGFR signaling interacts with TGFβ and PI3K/AKT pathways. This crosstalk determines periostin's role in tumor progression, refining our understanding of the molecular events underlying aggressive breast cancer phenotypes.

• Biofilm-Mediated Resistance to Hexetidine on PVC Surfaces

  2026-04-16

  This study provides direct evidence that biofilm formation on poly(vinyl chloride) (PVC), as found in endotracheal tubes, rapidly confers significant resistance to both antibiotics and non-antibiotic agents such as Hexetidine (NSC-17764). Atomic force microscopy reveals time-dependent glycocalyx development correlating with increased antimicrobial tolerance, emphasizing the clinical challenge of treating device-associated infections.

• Optimizing Mitochondrial Membrane Potential Assay with JC-1

  2026-04-15

  Uncover how the JC-1 Mitochondrial Membrane Potential Assay Kit streamlines apoptosis and mitochondrial function analysis with robust ratiometric detection. From immuno-oncology workflows to troubleshooting guidance, discover actionable strategies for reproducibility and data confidence.

• Liquid-Core Muco-Penetrating LNPs Enhance Intranasal mRNA De

  2026-04-14

  This study introduces ionizable lipid-incorporated liquid lipid nanoparticles (iLLNs) that penetrate respiratory mucus to dramatically improve intranasal mRNA delivery. By tuning lipid composition and surface properties, the authors achieve up to 60-fold higher nasal reporter gene expression and superior mucosal immunity compared to benchmark LNPs, with important implications for future mucosal mRNA vaccine design.

• IL-17A Drives Fibrosis in Neurogenic ED via mTORC2-ACACA Pat

  2026-04-13

  Yang et al. (2024) identify IL-17A as a central factor exacerbating corpus cavernosum fibrosis and neurogenic erectile dysfunction by promoting smooth muscle cell senescence through the mTORC2-ACACA pathway. Their findings provide mechanistic clarity and highlight novel therapeutic targets for improving outcomes after pelvic nerve injury.

• Wortmannin in Host-Pathogen Immunometabolism: New Insights f

  2026-04-12

  Explore how Wortmannin, a potent PI3K inhibitor, bridges immunometabolic signaling and autophagy in host-pathogen models. This article uniquely connects molecular mechanism with practical assay guidance and cross-domain applications in cancer and infectious disease research.

• Sisomicin: Advancing Translational Strategies Against Infect

  2026-04-12

  This thought-leadership article examines Sisomicin, a broad-spectrum aminoglycoside antibiotic, through the lens of mechanistic insight and translational research strategy. We explore its 30S ribosomal targeting, robust activity against Gram-negative and Gram-positive pathogens, and comparative positioning within the modern antibacterial landscape. Integrating evidence-based protocol parameters, clinical considerations, and future-facing perspectives, this piece guides infection researchers seeking reliable, reproducible, and impactful antibacterial workflows. References to APExBIO’s Sisomicin and critical literature further empower strategic decision-making.

456 records 21/31 page Previous Next First page 上5页 2122232425 下5页 Last page